Multicenter Clinical Evaluation of Etest Meropenem-Vaborbactam (bioMérieux) for Susceptibility Testing of Enterobacterales (Enterobacteriaceae) and Pseudomonas aeruginosa

Meropenem-vaborbactam (MEV) is a novel carbapenem–beta-lactamase inhibitor combination antibiotic approved by the U.S. Food and Drug Administration (FDA) for treatment of complicated urinary tract infections, including pyelonephritis, in adults. In this study, we evaluated the performance of Etest M...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Clin Microbiol
Autori principali: Jean, Sophonie, Garrett, Sheri, Anglade, Claire, Bridon, Laurence, Davies, Leanne, Garner, Omai B., Richards, Jennifer, Wallace, Meghan, Wootton, Mandy, Burnham, Carey-Ann D.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology 2019
Soggetti:
Bacteriology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6935911/
https://ncbi.nlm.nih.gov/pubmed/31619532
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.01205-19
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi